Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Cue Health Inc. HLTHQ OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
30/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Cue Health Inc. (HLTHQ) is a Medical - Devices company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 29/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $64M, +828.1%/yr average growth. Net income is $373M (loss), growing at -202.9%/yr. Net profit margin is -581.5% (negative). Gross margin is -97.9% (-132.8 pp trend).

Balance sheet: total debt is $48M against $250M equity (Debt-to-Equity (D/E) ratio 0.19, conservative). Current ratio is 2.54 (strong liquidity). Debt-to-assets is 14.1%. Total assets: $340M.

Analyst outlook: 0 / 1 analysts rate HLTHQ as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 67/100 (Partial), Moat 0/100 (Fail), Future 20/100 (Fail), Income 10/100 (Fail).

HLTHQ SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 20/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — HLTHQ

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
HLTHQ: +828.1%/yr revenue is, -202.9%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✗
PAST Fail
25/100
HLTHQ: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
~
HEALTH Partial
67/100
Balance sheet HLTHQ: Debt-to-Equity (D/E) ratio 0.19 (conservative), Current ratio is 2.54 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
✗
FUTURE Fail
20/100
Analyst outlook: 0 / 1 analysts rate HLTHQ as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
✗
INCOME Fail
10/100
HLTHQ: Net profit margin is -581.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.000001-0.0001
Volume12.89K
Avg Volume (30D)6.84K
Market Cap$159.00
Beta (1Y)0.69
Share Statistics
EPS (TTM)-2.44
Shares Outstanding$152.88M
IPO Date2021-09-24
Employees726
CEOClint Sever
Financial Highlights & Ratios
Revenue (TTM)$64.22M
Gross Profit$-62.87M
EBITDA$-311.23M
Net Income$-373.46M
Operating Income$-394.85M
Total Cash$81.69M
Total Debt$47.94M
Net Debt$-32.95M
Total Assets$339.79M
Price / Earnings (P/E)-0
Price / Sales (P/S)0
Analyst Forecast
Rating ConsensusHold
Analysts Covering1
Buy 0% Hold 100% Sell 0%
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2297901009

Price Chart

Track all markets on TradingView
HLTHQ
Cue Health Inc. ↗  ·  Other OTC
Healthcare • Medical - Devices
0.00 52WK RANGE 0.00

People Also View

LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
 RHHBF
RHHBF
Roche Holding AG
$415.00
-0.84%
 RHHBY
RHHBY
Roche Holding AG
$50.99
-0.08%
 AZN
AZN
AstraZeneca PLC
$201.21
-1.55%
 NVS
NVS
Novartis AG
$152.08
-0.85%
 MRK
MRK
Merck & Co., Inc.
$117.90
-1.72%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message